| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 07/10/2013 | CN103194521A Detection method for activity of kinase inhibitor in colon cancer cells |
| 07/10/2013 | CN103194228A Long-lasting phosphorescent material with optical excitation characteristic for biological imaging and preparation method and application thereof |
| 07/10/2013 | CN103194222A Preparation method and application of Fe3O4/ZnO composite nano-particles |
| 07/10/2013 | CN103191446A Preparation method of nuclear magnetic resonance contrast medium |
| 07/10/2013 | CN103191060A Amphipathic carboxymethyl glucan-modified magnetic lipidosome, and preparation and application methods thereof |
| 07/10/2013 | CN102552940B Microwave-assisted method for preparing magnetic resonance imaging contrast agent |
| 07/10/2013 | CN102329374B Gastric-cancer targeted peptide and application thereof |
| 07/10/2013 | CN102212116B Acetylcholine receptor mediated brain-targeted polypeptide and application thereof |
| 07/10/2013 | CN101547706B Magnetic resonance imaging contrast agents comprising zinc-containing magnetic metal oxide nanoparticles |
| 07/10/2013 | CN101180400B Nanoparticles comprising RNA ligands |
| 07/09/2013 | US8481478 Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry |
| 07/09/2013 | US8481056 Pro-apoptotic bacterial vaccines to enhance cellular immune responses |
| 07/09/2013 | US8481000 Thickened beverages for dysphagia |
| 07/04/2013 | WO2013101902A2 Chromophoric polymer dots with narrow-band emission |
| 07/04/2013 | WO2013071413A8 Methods for the synthesis of 13c labeled iodotridecane and use as a reference standard |
| 07/04/2013 | WO2013071412A8 Methods for the synthesis of 13c labeled plasmalogen |
| 07/04/2013 | WO2013071411A8 Methods for the synthesis of 13c labeled dha and use as a reference standard |
| 07/04/2013 | US20130172737 Absorbable sponge with contrasting agent |
| 07/04/2013 | US20130171205 Nanocell Drug Delivery System |
| 07/04/2013 | US20130171074 Targeting compounds |
| 07/04/2013 | US20130171073 Treatment of pituitary corticotroph tumors using r-roscovitine |
| 07/04/2013 | US20130171072 Dyes and methods of selecting dyes for use in personal care products |
| 07/04/2013 | US20130171071 Novel Imidazolium Salts and Carbene Metal Complexes Based Thereon for Use as Bioanalytical Markers for Biomolecules |
| 07/04/2013 | US20130171066 Polymeric complements to a b-amyloid peptides |
| 07/04/2013 | US20130171065 In Vivo Copper-Free Click Chemistry for Delivery of Therapeutic and/or Diagnostic Agents |
| 07/04/2013 | US20130171064 Anti-CD74 Immunoconjugates and Methods of Use |
| 07/04/2013 | US20130171061 Anti-human transferrin receptor antibody and uses thereof |
| 07/03/2013 | EP2610631A1 Device and method for rapid dynamic nuclear polarisation |
| 07/03/2013 | EP2609935A1 Switching fluorescent nanoparticle probe and fluorescent particle imaging method using same |
| 07/03/2013 | EP2609934A1 Receptor And Antigen Targeted Prodrug |
| 07/03/2013 | EP2609218A1 Methods and kits for predicting the risk of diabetes associated complications using genetic markers and arrays |
| 07/03/2013 | EP2608661A1 Animal model for the evaluation of the efficacy of an hiv vaccine |
| 07/03/2013 | CN103184235A Multiple anti-FMD shRNA tandem expression vector as well as construction method and application thereof |
| 07/03/2013 | CN103183697A Near-infrared boron dipyrromethene (BODIPY) compound based on duplex heterocyclic pyrrole group, and preparation method and application of BODIPY compound |
| 07/03/2013 | CN103182088A PLGA modified magnetic nanocluster and preparation method and application thereof |
| 07/02/2013 | US8475837 Abuse potential reduction in abusable substance dosage form |
| 07/02/2013 | US8475792 Molecules with extended half-lives, compositions and uses thereof |
| 07/02/2013 | US8475767 Anti-trypanosomal peptides and uses thereof |
| 07/02/2013 | US8475766 Dual specificity antibodies and methods of making and using |
| 07/02/2013 | US8475763 Method of determining the course of treatment for a patient having adenocarcinoma |
| 07/02/2013 | CA2579937C Methods for antibody library screening |
| 06/27/2013 | WO2013095273A1 Contrast agent for imagining myocardial perfusion |
| 06/27/2013 | WO2013092783A1 Stabilization of x-ray diagnostic composition |
| 06/27/2013 | WO2013058774A8 Compositions comprising ascorbic acid and an imaging agent and related methods |
| 06/27/2013 | WO2013058482A3 Multi-functional nucleic acid-based anti-cancer drug capable of targeting and therapy, method for preparing same and anti-cancer composition comprising same |
| 06/27/2013 | US20130167255 Screening method for anticancer drugs |
| 06/27/2013 | US20130165391 B2-glycoprotein i peptide inhibitors |
| 06/27/2013 | US20130164224 Contrast medium composition with contrast enhancement effect by comprising highly concentrated contrast agent |
| 06/27/2013 | US20130164223 Iron oxide nanocapsules, method of manufacturing the same, and mri contrast agent using the same |
| 06/27/2013 | US20130164222 Preparation of Extremely Small and Uniform Sized, Iron Oxide-Based Paramagnetic or Pseudo-Paramagnetic Nanoparticles and MRI T1 Contrast Agents Using the Same |
| 06/27/2013 | US20130164221 Use of bacterial beta-lactamase for in vitro diagnostics and in vivo imaging, diagnostics and therapeutics |
| 06/27/2013 | US20130164220 Collagen mimetic peptides for targeting collagen strands for in vitro and in vivo imaging and therapeutic use |
| 06/26/2013 | EP2606912A1 Contrast medium composition with contrast enhancement effect by comprising highly concentrated agent |
| 06/26/2013 | EP2606911A1 Receptor And Antigen Targeted Prodrug |
| 06/26/2013 | EP2606353A1 Circulating biomarkers for disease |
| 06/26/2013 | EP2605800A1 Process for producing radiohalogenated bioconjugates and products thereof |
| 06/26/2013 | EP2605774A1 Molecular switch |
| 06/26/2013 | CN103180364A Biocompatible agent for dispersing nanoparticles into an aqueous medium using mussel adhesive protein-mimetic polymer |
| 06/26/2013 | CN103179990A Endoscopic observation method and composition for improving diagnostic performance involving applying useful white opaque substance to diagnosis of gastric epithelial tumors (adenoma/gastric cancer) |
| 06/26/2013 | CN103172869A Biodegradable unimolecular multi-support-arm polymer as well as preparation method f and application thereof |
| 06/26/2013 | CN103172819A Biodegradable polyurethane with amino on side chain and preparation method and application thereof |
| 06/26/2013 | CN103169988A Contrast medium composition with contrast enhancement effect by comprising highly concentrated agent |
| 06/26/2013 | CN103169981A Method for eliminating and reducing generation of accelerated blood clearance phenomenon |
| 06/26/2013 | CN103169667A Preparation method of multifunctional meso-porous silicon nano preparation carrying gossypol derivative |
| 06/26/2013 | CN102580124B Medical disinfecting ultrasound gel composition and preparation method |
| 06/26/2013 | CN102370995B Contrast agent nanocapsule with whole-sealing hollow structure and template-method assembling technology |
| 06/25/2013 | US8471061 5-aminolevulinic acid salt, process for producing the same and use thereof |
| 06/25/2013 | US8470785 Method for treating ocular cancer |
| 06/25/2013 | US8470610 Retentate chromatography and protein chip arrays with applications in biology and medicine |
| 06/25/2013 | US8470528 Methods and compositions related to adenoassociated virus-phage particles |
| 06/25/2013 | US8470338 Method for preventing or treating M tuberculosis infection |
| 06/25/2013 | US8470300 Coated sensors and methods related thereto |
| 06/25/2013 | US8470298 Method of preparing a medium with bubbles formed therein for contemporaneous injection |
| 06/25/2013 | US8470294 Flexible and/or elastic brachytherapy seed or strand |
| 06/25/2013 | US8469034 Stem cell targeting and activation using magnetic particles |
| 06/25/2013 | CA2313169C Engraftable neural progenitor and stem cells for brain tumor therapy |
| 06/20/2013 | WO2013088395A1 Clicked somatostatin conjugated analogs for biological applications |
| 06/20/2013 | WO2013088382A1 Therapy for subarachnoid hemorrhage and ischemia |
| 06/20/2013 | WO2013087234A1 Nanoparticles and uses thereof |
| 06/20/2013 | US20130156706 Targeted gas-filled microvesicles |
| 06/20/2013 | US20130156705 Bivalent multifunctional ligands targeting a[beta] oligomers as treatment for alzheimer's disease |
| 06/20/2013 | US20130156704 Therapy for subarachnoid hemorrhage and ischemia |
| 06/20/2013 | US20130156702 Methods for the treatment and the diagnosis of cancer |
| 06/20/2013 | US20130156698 Tissue targeting |
| 06/19/2013 | EP2604289A2 Radial shape of polymer compound containing iodine, preparation method thereof, and ct contrast medium composition containing same |
| 06/19/2013 | EP2604288A1 Nanoparticles and uses thereof |
| 06/19/2013 | EP2604284A1 Receptor And Antigen Targeted Prodrug |
| 06/19/2013 | EP2604283A1 Receptor And Antigen Targeted Prodrug |
| 06/19/2013 | EP2604281A1 Clicked somatostatin conjugated analogs for biological applications |
| 06/19/2013 | EP2603589A1 Fluorescent proteins with increased activity in cells |
| 06/19/2013 | EP2603242A1 Targeted gas-filled microvesicles |
| 06/19/2013 | EP2603207A2 Oral controlled release pharmaceutical compositions of blonanserin |
| 06/19/2013 | EP2603200A1 Polymerized micelles for diagnosis |
| 06/19/2013 | CN103160539A Double-reporter-gene recombinant adenovirus vector, construction method and application thereof |
| 06/19/2013 | CN103160513A MUC1 protein nucleic acid aptamer, complex, composition and purposes thereof |
| 06/19/2013 | CN103160467A A poorly differentiated thyroid cancer cell line PDTC-1 and applications thereof |
| 06/19/2013 | CN103157118A Composite nano-grade novel material based on cancer early-stage integrated detection, diagnoses, and treatment, and preparation method thereof |
| 06/19/2013 | CN102552942B Magnetic mesoporous nano-composite material responding to external temperature or pH value and preparation method and application thereof |
| 06/19/2013 | CN101878044B Non-spherical contrast agents for cest mri based on bulk magnetic susceptibility effect |
| 06/19/2013 | CN101316616B Method of dynamic nuclear polarisation (DNP) using a trityl radical and a paramagnetic metal ion |